Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone

2003582 citationsJournal Articlebronze Open Access

Authors

Paul J. Fudala · University of Pennsylvania

T. Peter Bridge

Susan Herbert

William O. Williford · University of Maryland, Baltimore

C. Nora Chiang

Karen Jones

Joseph F. Collins · University of Maryland, Baltimore

Dennis W. Raisch · University of New Mexico

Paul Casadonte

Abstract

Buprenorphine and naloxone in combination and buprenorphine alone are safe and reduce the use of opiates and the craving for opiates among opiate-addicted persons who receive these medications in an office-based setting.

Topics & Keywords

Opioid Use Disorder Treatment Forensic Toxicology and Drug Analysis Neurotransmitter Receptor Influence on Behavior

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 349, Issue 10, pp. 949-958

DOI: 10.1056/nejmoa022164

Field-Weighted Citation Impact: 24.92